Papers
2
Total Citations
27
H-Index
2
About
N. Koenig is a pioneering researcher in the field of automated cell therapy manufacturing, with a focus on advanced therapeutic medicinal products (ATMPs) and regenerative medicine. Their major contributions center on developing robotic platforms that enable the closed, scalable, and Good Manufacturing Practice (GMP)-compliant production of cell therapies, addressing critical bottlenecks in translating novel treatments from bench to bedside. Koenig's most cited work, "Needle to needle robot‐assisted manufacture of cell therapy products" (2022, 17 citations), presents a fully automated system for producing high-quality clinical-grade cells, replacing costly, high-risk manual processes. Their earlier foundational study, "The AUTOSTEM platform for closed manufacture of bone marrow-derived mesenchymal stromal cells" (2017, 10 citations), demonstrated a closed, scalable robotic system for manufacturing mesenchymal stromal cells, a key cell type for regenerative therapies. These innovations have significant impact by reducing contamination risks, lowering costs, and increasing production scale, making cell therapies more accessible. Koenig's work is notable for advancing the automation of cell therapy manufacturing, a critical step toward widespread clinical adoption and commercialization of these life-saving treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2